Auditory function and dysfunction: estrogen makes a difference.
Amandine DelhezPhilippe LefebvreChristel PéqueuxBrigitte MalgrangeLaurence DelacroixPublished in: Cellular and molecular life sciences : CMLS (2019)
Estrogen is the major female hormone involved in reproductive functions, but it also exerts a variety of additional roles in non-reproductive organs. In this review, we highlight the preclinical and clinical studies that have pointed out sex differences and estrogenic influence on audition. We also describe the experimental evidences supporting a protective role of estrogen towards acquired forms of hearing loss. Although a high level of endogenous estrogen is associated with a better hearing function, hormonal treatments at menopause have provided contradictory outcomes. The various factors that are likely to explain these discrepancies include the treatment regimen as well as the hormonal status and responsiveness of the patients. The complexity of estrogen signaling is being untangled and many downstream effectors of its genomic and non-genomic actions have been identified in other systems. Based on these advances and on the common physio-pathological events that underlie age-related, drug or noise-induced hearing loss, we discuss potential mechanisms for their protective actions in the cochlea.
Keyphrases
- hearing loss
- estrogen receptor
- end stage renal disease
- ejection fraction
- newly diagnosed
- copy number
- polycystic ovary syndrome
- oxidative stress
- postmenopausal women
- type diabetes
- peritoneal dialysis
- stem cells
- emergency department
- drug induced
- gene expression
- climate change
- risk assessment
- mesenchymal stem cells
- bone marrow
- metabolic syndrome
- working memory
- human health
- dna methylation
- electronic health record